Satoshi Mori

7PUBLICATIONS
8CO-AUTHORS
Occupational therapyOrthopticsToxicology (incl. clinical toxicology)Predictive and prognostic markersRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 13, 2026
Correction: Time-dependent improvement of quality of life with teriparatide or alendronate therapy: a JOINT-05 sub-analysis.

Satoshi Mori, Shiro Tanaka, Tatsuhiko Kuroda

|Jul 31, 2025
Time-dependent improvement of quality of life with teriparatide or alendronate therapy: a JOINT-05 sub-analysis.

Satoshi Mori, Shiro Tanaka, Tatsuhiko Kuroda

|Mar 22, 2025
Sequential therapy following teriparatide treatment in patients at high risk of osteoporotic patients.

Satoshi Mori

|Jan 27, 2023
Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene.

Hiroaki Ohta, Yukari Uemura, Teruki Sone

|Oct 14, 2022
Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05.

Satoshi Mori, Hiroshi Hagino, Toshitsugu Sugimoto

|Aug 27, 2021
Correction to: A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese osteoporosis intervention Trial-05.

H Hagino, T Sugimoto, S Tanaka

Pageof 2

Frequent Collaborators

3 joint publications

Hiroshi Hagino

3 joint publications

Shiro Tanaka

3 joint publications

Satoshi Soen

1 joint publications

Hiroaki Ohta